National Data Archive
Data Catalog
  • Home
  • Microdata Catalog
  • Citations
  • Login
    Login
    Home / Central Data Catalog / FRESH-PEF73059-EN
central

Cross-sectional study of surveillance of suspicious prescriptions, indicators of possible abuse

France, 1991 - 3000
Reference ID
FRESH-PEF73059-en
Producer(s)
Maryse;LAPEYRE-MESTRE
Metadata
DDI/XML JSON
Study website Interactive tools
Created on
Feb 18, 2026
Last modified
Feb 18, 2026
Page views
1
  • Study Description
  • Get Microdata
  • Identification
  • Scope
  • Coverage
  • Producers and sponsors
  • Sampling
  • Survey instrument
  • Data collection
  • Study activities
  • Quality standards
  • Data Access
  • Contacts
  • Metadata production
  • Identification

    Survey ID number

    FRESH-PEF73059-en

    Title

    Cross-sectional study of surveillance of suspicious prescriptions, indicators of possible abuse

    Abbreviation or Acronym

    OSIAP

    Country
    Name Country code
    France fr
    Kind of Data

    ['Participant-reported health data']

    Unit of Analysis

    Individuals

    Scope

    Topics
    Topic Vocabulary
    General medicine health theme
    Psychiatry health theme
    Addiction medicine health theme
    Disorders due to use of unknown or unspecified psychoactive substances cim-11
    Behavioral determinants: Addiction health determinant
    Healthcare system determinants: Use of care health determinant
    Behavioral determinants health determinant
    Healthcare system determinants health determinant
    Keywords
    pharmacy abuse indicator prescription surveillance medicines

    Coverage

    Universe

    {
    "level_sex_clusion_I": [
    {
    "value": "Male",
    "concept": {
    "vocab": "MeSH",
    "vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D008297"
    }
    },
    {
    "value": "Female",
    "concept": {
    "vocab": "MeSH",
    "vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D005260"
    }
    }
    ],
    "level_age_clusion_I": [
    {
    "value": "Young Adult (19 to 24 years)",
    "concept": {
    "vocab": "MeSH",
    "vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D055815"
    }
    },
    {
    "value": "Adult (25 to 44 years)",
    "concept": {
    "vocab": "MeSH",
    "vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D000328"
    }
    },
    {
    "value": "Middle Aged (45 to 64 years)",
    "concept": {
    "vocab": "MeSH",
    "vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D008875"
    }
    },
    {
    "value": "Aged (65 to 79 years)",
    "concept": {
    "vocab": "MeSH",
    "vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D000368"
    }
    },
    {
    "value": "Aged, 80 and over (80 years and more)",
    "concept": {
    "vocab": "MeSH",
    "vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D000369"
    }
    }
    ],
    "level_type_clusion_I": [
    "Patients population"
    ],
    "level_type_clusion_other": "",
    "clusion_I": "All suspicious prescriptions (coming from CEIP network pharmacies) during the month of the study, registered on a collection form that includes, for each prescription, the demographic characteristics of the requester (sex, age), the name of the medicine(s) involved and the suspicious prescription criteria. The definition of the term \"suspicious prescription\" corresponds to a prescription that is not the translation of a medical prescription according to the accepted regulatory criteria. It therefore includes: - prescriptions written from a stolen prescription, prescriptions that are photocopied, scanned, prepared on a PC; - prescriptions that have been modified, i.e. valid prescriptions that have subsequently been modified (by addition of a medicine not initially included, or by modification of the dosage or duration of the treatment); - clearly abnormal prescriptions that are not included in the first two situations.",
    "clusion_E": ""
    }

    Producers and sponsors

    Primary investigators
    Name
    Maryse;LAPEYRE-MESTRE
    Producers
    Name Role
    CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE (CHUT) sponsor
    Funding Agency/Sponsor
    Name
    AGENCE NATIONALE DE SECURITE DU MEDICAMENT ET DES PRODUITS DE SANTE (ANSM)
    INTERMINISTERIEL
    Other Identifications/Acknowledgments
    Name
    EMCDDA (6 countries, for which France is the project coordinator); Réseau français d'addictovigilance (French drug dependence assessment system)

    Sampling

    Sample frame

    Unit Type

    ['Through independent healthcare practitioners']

    Sampling Procedure

    ['{"concept":{"vocabURI":"Other","vocab":"CESSDA"},"value":"Other"}']

    Survey instrument

    Questionnaires

    Access on specific project only

    Methodology notes

    Observational Study

    Data collection

    Dates of Data Collection
    Start End
    1991-01-01 3000-01-01
    Time Method

    One-time cross-sectional study

    Mode of data collection
    • {"concept":{"vocabURI":"Interview","vocab":"CESSDA"},"value":"Interview with the participant (including clinical)"}

    Study activities

    Study activities
    Study activities
    Type
    primary evaluation
    Description
    Health care consumption and services

    Quality standards

    Quality standards
    Standard
    ['ATC classification for the registration of medicines']

    Data Access

    Availability Status

    {"value":"Restricted access","extLink":[{"title":"COAR","uri":"http://purl.org/coar/access_right/c_16ec"}]}

    Restrictions

    Database accessible as part of regulatory activities related to drug abuse and dependence monitoring overseen by ANSM. No direct access to the database. Possibility of collaboration as part of a research project (contact scientific supervisor)

    Contacts

    Contacts
    Name Email
    Maryse;LAPEYRE-MESTRE maryse.lapeyre-mestre@univ-tlse3.fr

    Metadata production

    DDI Document ID

    FRESH-PEF73059-en

    Producers
    Name Affiliation
    Maryse LAPEYRE-MESTRE CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE (CHUT)
    Back to Catalog
    National Data Archive

    © National Data Archive, All Rights Reserved.